Amaero Ltd (ASX:3DA)

CTI BioPharma Revenue

Amaero had revenue of 1.66M AUD in the half year ending December 31, 2024, with 2,337.79% growth. This brings the company's revenue in the last twelve months to 2.01M, up 1,621.11% year-over-year. In the fiscal year ending June 30, 2024, Amaero had annual revenue of 463.86K with 579.14% growth.

• Revenue (ttm): 2.01M
• Revenue Growth: +1,621.11%
• P/S Ratio: 160.37
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 322.00M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	463.86K	395.56K	579.14%
Jun 30, 2023	68.30K	-501.53K	-88.01%
Jun 30, 2022	569.83K	65.69K	13.03%
Jun 30, 2021	504.14K	387.56K	332.43%
Jun 30, 2020	116.58K	-	-